The role involves building and leading a high-performing team to accelerate AstraZeneca's emerging Cell Therapy modalities portfolio.
Base: $97,372.00 - $146,058.00; Bonus/Equity: Short-term incentive bonus and equity-based long-term program available; Benefits: 401(k), paid vacation, holidays, medical, dental, vision coverage
Must-have
Nice-to-have
Not specified